Evaluation of glucosamine coated mesoporous silica nanoparticles for antioxidant activity cytocompatibility and blood brain barrier permeability in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) remains a fatal neurodegenerative disease with limited disease-modifying options, and effective delivery of therapeutics to the central nervous system is hindered by the blood–brain barrier (BBB). Here, we report mesoporous silica nanoparticles (MSNs) designed as a combination-delivery platform integrating riluzole, 5-methoxytryptamine (5MT) as an antioxidant-related component, and glucosamine as a biomolecular surface coating. The resulting multifunctional nanosystems were prepared and characterized by complementary physicochemical techniques, supporting successful incorporation of the selected components within the MSN-based carrier. To obtain a first-pass indication of brain-oriented delivery feasibility, permeability was assessed using a PAMPA-BBB assay that mimics key features of the brain lipid environment. This screening assay showed formulation-dependent apparent silica carryover across the artificial lipid membrane and provides a basis for subsequent evaluation in cell-based BBB models, supporting their further evaluation as ALS-oriented nanodelivery candidates. Overall, these results establish a rational proof-of concept of MSN platform for combination delivery and provide a permeability-screening basis for subsequent studies in more advanced BBB and neurobiological models, supporting their further evaluation as multifunctional delivery platforms for neurodegenerative diseases, such as ALS.

Authors

Institutions

Publication Details

Journal
Discover Nano
Published
2026-11-19
DOI
https://doi.org/10.1186/s11671-026-05075-7
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of glucosamine coated mesoporous silica nanoparticles for antioxidant activity cytocompatibility and blood brain barrier permeability in amyotrophic lateral sclerosis

Victoria García‐Almodóvar, Santiago Gómez‐Ruiz, Diana Díaz‐García, Nagore Grasa-Gude
Discover Nano
Nanoparticle-Based Drug Delivery
article

Evaluation of glucosamine coated mesoporous silica nanoparticles for antioxidant activity cytocompatibility and blood brain barrier permeability in amyotrophic lateral sclerosis

Victoria García‐Almodóvar, Santiago Gómez‐Ruiz, Diana Díaz‐García, Nagore Grasa-Gude
article en

Abstract

Amyotrophic lateral sclerosis (ALS) remains a fatal neurodegenerative disease with limited disease-modifying options, and effective delivery of therapeutics to the central nervous system is hindered by the blood–brain barrier (BBB). Here, we report mesoporous silica nanoparticles (MSNs) designed as a combination-delivery platform integrating riluzole, 5-methoxytryptamine (5MT) as an antioxidant-related component, and glucosamine as a biomolecular surface coating. The resulting multifunctional nanosystems were prepared and characterized by complementary physicochemical techniques, supporting successful incorporation of the selected components within the MSN-based carrier. To obtain a first-pass indication of brain-oriented delivery feasibility, permeability was assessed using a PAMPA-BBB assay that mimics key features of the brain lipid environment. This screening assay showed formulation-dependent apparent silica carryover across the artificial lipid membrane and provides a basis for subsequent evaluation in cell-based BBB models, supporting their further evaluation as ALS-oriented nanodelivery candidates. Overall, these results establish a rational proof-of concept of MSN platform for combination delivery and provide a permeability-screening basis for subsequent studies in more advanced BBB and neurobiological models, supporting their further evaluation as multifunctional delivery platforms for neurodegenerative diseases, such as ALS.

Discover NanoVol. 21(1)
Universidad Rey Juan Carlos (ES)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon